Course Title: Strategy Planning

Assignment No: 3

Program : BSCM-BSAF

Section : F-17

Submitted to:
Sir Amjad Ali

Submitted by:
Ayesha Hamid L1F17BSCM0024
Moattar Zahra L1F17BSCM0020
Amna noor tayyab L1F17BSCM0021
Zuraiz ali L1S18BSAF0004
Zara siddique L1F17BSCM0002
 External Factor Evaluation Matrix
Key External Factor Weight Rating Weighted
score
Opportunities
1. Increasing elderly population worldwide. 0.03 2 0.06
2. Strategic Acquisition 0.09 4 0.36
3. Focusing on Research & Development for 0.07 4 0.28
Chronic diseases vs. Acute diseases
4. Driving out competitors with lower prices 0.03 2 0.06

5. Potential drug revenues after a competitor‘s 0.03 2 0.06

patent expired.
6. Penetration of Vaccine and Biologics for 0.04 4 0.16
emerging international markets
7. Product Diversification through Acquisitions 0.07 4 0.28

8. Diversification into biologics, diabetes, 0.06 4 0.24

oncology, and infectious market segments
9. Constant growth of pharmaceutical and Health 0.08 2 0.16
Care Industry by 10%
10. Educate staff to promote loyalty through 0.07 2 0.14
relationships from distribution channels
Threats
1. Risk of expensive class action law suits 0.06 1 0.06

2. Loss of patent protection 0.08 2 0.16

3. Tightening of FDA Regulatory Oversight 0.04 2 0.08

4. Increased global competition 0.02 3 0.06

5. Price of prescription drugs increase which is 0.03 2 0.06

reducing Medicaid drug benefits
6. Failure to identify risks due to lack of time & 0.02 2 0.04
study of long term effects
7. Compete with smaller generic company along 0.03 3 0.09
with other larger firms
8. Expensive Research & Development costs 0.04 3 0.12

9. Industry marked by rapid advances 0.03 3 0.09

10. Hard to forecast external factors 0.08 1 0.08

Total 1.00 2.64

Competitive Profile Matrix (CPM)

Critical success SANOFI PFIZER NOVARTIS
factors (CSF) Weight AVENTIS
Rating Score Rating Score Rating Score

1. Product safety
and efficacy 0.20 4 0.80 3 0.60 3 0.60
2. Broad product
portfolio 0.15 4 0.60 4 0.60 4 0.60
3. Product
marketing and 0.15 2 0.30 4 0.60 3 0.45
brand awareness
4. Buyer
relationship 0.10 3 0.30 4 0.40 3 0.30
5. Distributor
relationship 0.11 2 0.22 2 0.22 2 0.22
6. Accessibility and
supply availability 0.12 3 0.36 4 0.48 4 0.48
7. Business ethics
0.08 4 0.32 3 0.24 3 0.24
8. Financial
capacity 0.09 3 0.27 4 0.36 4 0.36

TOTAL 1.00 3.17 3.50 3.25